You are here
The editorial board selects journal articles that have been peer-reviewed and accepted for publication. The editorial independence of the resource centre is of the utmost importance. The articles and other material published on the resource centre have been selected solely by the editorial board independently and without influence from Elsevier or the sponsor.
Editor in Chief
Professor Colagiuri is currently Professor of Metabolic Health and Director of The Boden Institute at the University of Sydney and Co-Director of the World Health Organization Collaborating Centre on Physical Activity, Nutrition and Obesity. His research interests focus on the development and implementation of evidence-based guidelines, cardio-metabolic and vascular risk assessment, diabetes screening and prevention, economic aspects of diabetes and obesity, and diabetes care delivery. Professor Colagiuri has been President of the Australian Diabetes Society and Chair of the International Diabetes Federation Task Force on Clinical Guidelines. He is a member of the Diabetes Expert Advisory Committee of the Commonwealth Department of Health (Australia) and an advisor on diabetes to the World Health Organization. Professor Colagiuri is currently Editor-in-Chief of the IDF journal Diabetes Research and Clinical Practice and has published over 200 scientific papers.
Dr Francesc Xavier Cos is Director of Sant Martí Primary Health Centres (Catalonian Health Institute), Barcelona, Spain, managing over 100 professionals, including 27 GPs. He has been a general practitioner in Barcelona and member of the Grup d'estudi de la diabetis a l'Atenció Primària de salut (GEDAPS) Primary Care Diabetes Study Group since 1997. He has been a member of The Primary Care Diabetes Research Network (Fundació Jordi Gol i Gurina) and of the Spanish Primary Care Diabetes research Network (redIAPP) endocrinology division since 2001. He has also been their European representative since 2004. Professor Cos has been Vice Chair of Primary Care Diabetes Europe (PCDE) since 2009.
Vivian A. Fonseca was awarded a Bachelor of Medicine and a Bachelor of Surgery from the Armed Forces Medical College in Poona, India, and earned his MD from University of Bombay (now the University of Mumbai) in Mumbai, India. He completed residency training in internal medicine at the Royal Free Hospital in London, UK, along with a fellowship in endocrinology with the UK National Health Service. Between 1992 and 1998 he was a faculty member for the Division of Endocrinology at the University of Arkansas for Medical Sciences in Little Rock, AR, USA. Since 1998 he has served as Professor of Medicine, Tullis–Tulane Alumni Chair in Diabetes, and Chief of the Section of Endocrinology at Tulane University Health Sciences Center in New Orleans, LA, USA. Over the course of his career Dr Fonseca has conducted trials for most diabetes drugs on the market.
Professor Fonseca is former President, Medicine & Science of the American Diabetes Association. He is currently Editor-in-Chief of the Journal of Diabetes Complications, and an ad hoc reviewer for several other journals including The New England Journal of Medicine, The Journal of the American Medical Association (JAMA), Diabetes, Diabetic Medicine, Kidney International, The American Journal of Clinical Nutrition, British Medical Journal (BMJ), and Metabolism. Between 2007 and 2012 he was Editor-in-Chief of Diabetes Care, having formerly been Associate Editor. Previous to this he was Editor-in-Chief of Metabolic Syndrome and Related Disorders. Between 2003 and 2006 he served on the editorial board of the Journal of Clinical Endocrinology and Metabolism.
Professor Fonseca is a fellow of the Royal College of Physicians, The American Association of Clinical Endocrinologists, and the American College of Physicians. He is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on several national and international committees and has published over 200 papers, review articles, and book chapters. He is the editor of the text book Clinical diabetes: translating research into practice.
In 2012 he received the American Diabetes Association Banting Medal for leadership and service.
Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester. He leads a research group that is currently working on the early identification of, and interventions with, people who have diabetes or are at increased risk of developing diabetes. His work has influenced national and international guidelines on the screening and management of people with diabetes. He is Director of NIHR CLAHRC East Midlands and Co-Director of a Clinical Trial Unit. He is a NIHR Senior Investigator and principal investigator on several major national and international studies. Professor Khunti is currently an advisor to the Department of Health, a Clinical Advisor for the National Institute for Health and Care Excellence (NICE), and Secretary of the Primary Care Study Group of the European Association for the Study of Diabetes (EASD). He is past Chair of the Department of Health–RCGP Committee on Classification of Diabetes and is currently Chair of the NICE Guidelines on Prevention of Diabetes. In addition, he is co-Director of the Diabetes MSc at Leicester University and the BMJ Diabetes Diploma.
Professor Mathieu is Professor of Medicine at the Catholic University of Leuven, Leuven, Belgium, and Chair of Endocrinology at the Catholic University of Leuven and its University Hospital in Gasthuisberg. She is a biomedical researcher with a translational focus. Professor Mathieu began as an Internist and worked as a physician-scientist in Gastrointestinal Motility. She received a PhD in Endocrinology and Transplant Immunology in 1994. Professor Mathieu completed a postdoctoral scholarship at the Research Foundation - Flanders (FWO-Vlaanderen and became a Professor in the School of Medicine at the Catholic University of Leuven and Supervisor in the Clinical Department of Endocrinology of the University Hospital of the Catholic University of Leuven in 1996. She became Professor of Medicine in 2002 and has held the Chair in Endocrinology since 2009. Professor Mathieu has been the recipient of many scholarships and research grants and several scientific prizes, including the Inbev-Baillet-Latour prize for Clinical Research. Professor Mathieu has provided key evidence for the understanding of the pathogenesis of T1D and indicated novel avenues to prevent or cure this disease.
Thomas Pieber is Head of the Division of Endocrinology and Metabolism, Department of Internal Medicine at the Medical University Graz, Head of the Institute of Biomedicine and Health Science of Joanneum Research, and CSO of CBmed - Center for Biomarker Research in Medicine. Professor Pieber’s research focuses on basic and clinical investigations in diabetes and endocrinology, outcome research, the effect of quality management systems, biomarkers and nanotoxicology and nanomedicine. He is author of more than 230 peer review articles or systematic reviews. He is a reviewer for several journals including Diabetologia, Diabetes, Diabetes Obesity and Metabolism and Diabetes Care. He is also a member of the Cochrane Review Group for Endocrine and Metabolic Diseases and was the President of the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna in 2009.
Professor Pieber has received a number of national and international awards including the Human Technology Interface Award of Styria (2014), the Somogyi Award 2010 and the Max Kade Fellowship of the Austrian Academy of Sciences. Additionally to having received grants from national and international publicly-funded projects, he has been reviewer for EFSD, NIH and the Austrian National Bank. He is member of the faculty for postdoctoral studies at Medical University of Graz and has been supervisor for over 30 PhD students.
Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk.
Search this site
Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk